Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer

Bibliographic Details
Main Authors: Chan, Arlene, Miles, D., Pivot, X.
Format: Journal Article
Published: Oxford University Press 2010
Online Access:http://hdl.handle.net/20.500.11937/7623
_version_ 1848745423182757888
author Chan, Arlene
Miles, D.
Pivot, X.
author_facet Chan, Arlene
Miles, D.
Pivot, X.
author_sort Chan, Arlene
building Curtin Institutional Repository
collection Online Access
first_indexed 2025-11-14T06:17:07Z
format Journal Article
id curtin-20.500.11937-7623
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:17:07Z
publishDate 2010
publisher Oxford University Press
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-76232017-02-28T01:31:21Z Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer Chan, Arlene Miles, D. Pivot, X. 2010 Journal Article http://hdl.handle.net/20.500.11937/7623 Oxford University Press restricted
spellingShingle Chan, Arlene
Miles, D.
Pivot, X.
Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
title Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
title_full Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
title_fullStr Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
title_full_unstemmed Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
title_short Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
title_sort bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
url http://hdl.handle.net/20.500.11937/7623